Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2129
https://www.valueinhealthjournal.com/article/S1098-3015(14)04059-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1597
First Page :
A609
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04059-5&doi=10.1016/j.jval.2014.08.2129